Image
Back to top
Dr Anna Moltó
Attending rheumatologist
Dr Anna Moltó is an attending rheumatologist in the Rheumatology Department of Cochin Hospital, Paris, France, and also acts as a clinical researcher in the INSERM ECAMO team (U-1153) from the University of Paris, France.
She completed both her medical studies and rheumatology training at Universitat Autónoma de Barcelona, Spain, in 2010. She completed a clinical research fellowship in Paris, and in 2011, was an assistant professor at Cochin Hospital. Dr Moltó was co-opted by Emerging EULAR Network (EMEUNET) in 2010, where she first served as part of the Country Liaisons subgroup, subsequently as its leader. She was elected Chair of EMEUNET in 2015.
Dr Moltó’s research focuses mainly on the natural history of early axial spondyloarthritis, evaluation of effectiveness in observational trials and pregnancy outcomes in patients with inflammatory rheumatic diseases. She has authored more than 100 peer-reviewed publications.
0 resources
Video1:13:07 min
Prof. Falk Bechara covers the different surgical options for HS, and experienced nurses from his team discuss the importance of wound care
EU-DC-2400105
Video1:19:16 min
Prof. Thrasyvoulos Tzellos gives an overview of HS treatment options. Dr Barry McGrath and Prof. Gregor Jemec provide their views on the HCP-patient relationship
EU-BK-2400245
Video1:11:49 min
Prof. Christos Zouboulis and Dr Axel Villani kick-off the webinar series by explaining the fundamentals of the HS disease story and pathophysiology
EU-DC-2400107
Video35 minutes watch
Accompany Dr William Tillett and Dr Fabian Proft as they explore the approaches and challenges of managing D2T patients with PsA.
EU-DA-2400672
Infographic2 minutes read
Achieving MDA or DAPSA treatment targets improves quality of life for patients with PsA.1–4 Explore the characteristics of patients who report treatment success...
EU-DA-2400673
Infographic2 minutes read
ASDAS and BASDAI are commonly used in clinical practice.1,2 However, discover recent studies demonstrating that a high proportion of real-world patients do not...
EU-DA-2400659